Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double Blind Double Dummy Control Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid

NCT03295383 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT03295383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03295383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double Blind Double Dummy Control Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid
Lead sponsor
University Hospital, Rouen
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 11, 2019
Completion date
March 31, 2027
Enrollment
92 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

severe forms of mucous membrane pemphigoid